MODERN CHINESE MEDICINE GROUP CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.375 HKD | 0.00% |
|
-6.25% | +10.29% |
| Mar. 22 | Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | Modern Chinese Medicine Warns of Up to 48% Profit Slump | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 400.9 | 291.4 | 185.4 |
| Enterprise Value (EV) 1 | 225.2 | 9.587 | -100.8 |
| P/E ratio | 4.85 x | 3.32 x | 3.8 x |
| Yield | 2.04% | - | - |
| Capitalization / Revenue | 1.11 x | 0.73 x | 0.54 x |
| EV / Revenue | 0.62 x | 0.02 x | -0.29 x |
| EV / EBITDA | 1.94 x | 0.07 x | -1.36 x |
| EV / FCF | -9.98 x | 0.1 x | 9.99 x |
| FCF Yield | -10% | 1,043% | 10% |
| Price to Book | 1.19 x | 0.69 x | 0.39 x |
| Nbr of stocks (in thousands) | 600,000 | 600,000 | 600,000 |
| Reference price 2 | 0.6681 | 0.4857 | 0.3090 |
| Announcement Date | 4/19/22 | 4/26/23 | 4/30/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 173.5 | 218.8 | 308.7 | 360.7 | 399.7 | 344.1 |
| EBITDA 1 | 65.39 | 78.33 | 106.2 | 115.8 | 134.2 | 74.36 |
| EBIT 1 | 63.74 | 76.84 | 104.7 | 113.6 | 129.1 | 68.37 |
| Operating Margin | 36.73% | 35.12% | 33.91% | 31.51% | 32.3% | 19.87% |
| Earnings before Tax (EBT) 1 | 64.51 | 65.26 | 90.48 | 114.2 | 124.3 | 68.31 |
| Net income 1 | 48.24 | 46.24 | 63.58 | 81.78 | 87.83 | 48.8 |
| Net margin | 27.8% | 21.14% | 20.6% | 22.67% | 21.98% | 14.18% |
| EPS | - | - | 0.1413 | 0.1377 | 0.1464 | 0.0813 |
| Free Cash Flow 1 | 68.63 | 40.72 | 44.51 | -22.56 | 99.95 | -10.09 |
| FCF margin | 39.55% | 18.61% | 14.42% | -6.26% | 25.01% | -2.93% |
| FCF Conversion (EBITDA) | 104.95% | 51.99% | 41.92% | - | 74.48% | - |
| FCF Conversion (Net income) | 142.28% | 88.07% | 70.01% | - | 113.8% | - |
| Dividend per Share | - | - | - | 0.0136 | - | - |
| Announcement Date | 12/31/20 | 12/31/20 | 4/26/21 | 4/19/22 | 4/26/23 | 4/30/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 89.9 | 25.6 | 67.7 | 176 | 282 | 286 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 68.6 | 40.7 | 44.5 | -22.6 | 100 | -10.1 |
| ROE (net income / shareholders' equity) | 48.4% | 48% | 62.4% | 34.6% | 23.1% | 10.9% |
| ROA (Net income/ Total Assets) | 27.5% | 32.4% | 39.4% | 23.5% | 18% | 8.3% |
| Assets 1 | 175.1 | 142.5 | 161.5 | 348.4 | 488.5 | 588.1 |
| Book Value Per Share | - | - | 0.3000 | 0.5600 | 0.7000 | 0.7900 |
| Cash Flow per Share | - | - | 0.1600 | 0.2900 | 0.4700 | 0.4800 |
| Capex 1 | 0.17 | 2.62 | 0.54 | 70 | 11.7 | 5.1 |
| Capex / Sales | 0.1% | 1.2% | 0.18% | 19.4% | 2.93% | 1.48% |
| Announcement Date | 12/31/20 | 12/31/20 | 4/26/21 | 4/19/22 | 4/26/23 | 4/30/24 |
1CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +10.29% | 28.77M | |
| +40.73% | 739B | |
| +31.06% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +14.96% | 240B | |
| +9.46% | 210B | |
| -5.15% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 1643 Stock
- Financials Modern Chinese Medicine Group Co., Ltd.
